Bioprocessing:Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work ), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463), Melanopsin (same as the one in our previous work ), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1-shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work , ). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work6), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463),Melanopsin (same as the one in our previouswork26), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work54,56). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Expressing:Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work ), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463), Melanopsin (same as the one in our previous work ), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1-shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work , ). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work6), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463),Melanopsin (same as the one in our previouswork26), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work54,56). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Plasmid Preparation:Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work ), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463), Melanopsin (same as the one in our previous work ), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1-shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work , ). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work6), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463),Melanopsin (same as the one in our previouswork26), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work54,56). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
shRNA:Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work ), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463), Melanopsin (same as the one in our previous work ), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1-shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work , ). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work6), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463),Melanopsin (same as the one in our previouswork26), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work54,56). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Control:Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work ), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463), Melanopsin (same as the one in our previous work ), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1-shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work , ). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work6), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463),Melanopsin (same as the one in our previouswork26), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work54,56). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Knockdown:Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work ), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463), Melanopsin (same as the one in our previous work ), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1-shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work , ). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
Article Title: Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement.
Article Snippet: .. AAV serotype 2/2 was used for the expression of LacZ (Vector Biolabs Cat No. 7003), GFP (Addgene plasmid# 105539), DIO-GFP (Addgene Plasmid# 51504), Cre (Penn Vector, Cat# P1848), CNTF (same as one in previously published work6), dAPEX2 (Addgene plasmid# 117176), hM3D(Gq) (Addgene plasmid# 50463),Melanopsin (same as the one in our previouswork26), and shRNA (Control-shRNA: GACCATCAATATGACTAGA; Lipin1shRNA: CGTGTCATATCAGCAATTT, the efficacy of Lipin1 knockdown was demonstrated in our previous work54,56). .. AAV serotype 2/9 was used for the expression of DIO-EGFP-TVA (BrainVTA, Cat# PT-0021), DIO-RVG (BrainVTA, Cat# PT-0023), and RV-ENVA-ΔG-dsRed (BrainVTA, Cat# R01002).
|